Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Stellate Ganglion Blockade (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes? A Pilot Prospective Cohort Study

NCT03796195 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03796195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03796195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Stellate Ganglion Blockade (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes? A Pilot Prospective Cohort Study
Lead sponsor
Northwestern University
Phase
Phase 4
Overall status
Terminated
Start date
November 13, 2019
Completion date
July 16, 2021
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hot flashes, prostate cancer